Ambu A/S

AMBU B

DK0060946788

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 05:42:45 2024-12-02 am EST			5-day change	1st Jan Change
112.05 ^DKK	+0.95%		-2.01%	+6.37%

Nov. 26	Bernstein initiates coverage of Ambu with a market perform recommendation - BN	FW
Nov. 14	Nordea Bank Upgrades Ambu to Buy	MT

Ambu A/S Announces Christian Sagild, Independent Director Decides Not to Run for Re-Election

November 08, 2024 at 06:15 am EST

Ambu A/S announced that at the AGM to be held on 4 December 2024, the company announced Christian Sagild, Independent Director decides not to run for re-election.

Latest news about Ambu A/S

Bernstein initiates coverage of Ambu with a market perform recommendation - BN	Nov. 26	FW
Nordea Bank Upgrades Ambu to Buy	Nov. 14	MT
Ambu A/S Announces Christian Sagild, Independent Director Decides Not to Run for Re-Election	Nov. 08	CI
DNB lowers target price for Ambu to DKK 140 (145), reiterates Buy - BN	Nov. 06	FW
Carnegie lowers target price for Ambu to 130 Danish kroner (135), reiterates hold - BN	Nov. 06	FW
Handelsbanken raises Ambu to marketperform (underperform) in the long term, target price SEK 140 (147)	Nov. 06	FW
SEB lowers target price for Ambu to DKK 155 (165), reiterates Buy - BN	Nov. 06	FW
Ambu A/S, Q4 2024 Earnings Call, Nov 05, 2024	Nov. 05
Ambu's organic growth lower than expected	Nov. 05	FW
Ambu A/S Provides Financial Guidance for the Year 2024/25	Nov. 04	CI
Ambu A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	Nov. 04	CI
Evaxion Biotech A/S Announces CFO Changes	Sep. 20	CI
SEB raises target price for Ambu to DKK 165 (160), reiterates Buy - BN	Sep. 19	FW
SEB Bank Upgrades Ambu to Buy	Sep. 02	MT
Today's stock recommendations at a glance	Sep. 02	FW
Danske Bank lowers target price for Ambu to DKK 140 (160), reiterates 'Hold' - BN	Sep. 02	FW
DNB raises target price for Ambu to DKK 145 (138), reiterates Buy - BN	Sep. 02	FW
Carnegie lowers target price for Ambu to DKK 135 (144), reiterates hold - BN	Sep. 02	FW
SEB raises Ambu to buy (hold), target price DKK 160 - BN	Sep. 02	FW
JP Morgan raises target price for Ambu to DKK 76 (59), reiterates neutral - BN	Sep. 02	FW
Ambu A/S, Q3 2024 Earnings Call, Aug 30, 2024	Aug. 30
Ambu's final results fully in line with preliminary data	Aug. 30	FW
Ambu A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	Aug. 30	CI
Carnegie raises target price for Ambu to DKK 144 (128), reiterates hold - BN	Aug. 23	FW
Danske Bank raises target price for Ambu to DKK 160 (130), reiterates 'Hold'	Aug. 19	FW

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).

Employees

5,196

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-12-04 - Annual General Meeting

More about the company